CNS Pharmaceuticals, Inc.

NasdaqCM:CNSP Stock Report

Market Cap: US$2.3m

CNS Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:CNSP Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
01 Feb 24BuyUS$50,000John ClimacoIndividual166,666US$0.30
01 Feb 24BuyUS$20,000Christopher DownsIndividual66,666US$0.30
01 Feb 24BuyUS$10,000Jerzy GumulkaIndividual33,333US$0.30
01 Feb 24BuyUS$10,000Carl EvansIndividual33,333US$0.30
22 Aug 23BuyUS$34,177Christopher DownsIndividual27,000US$1.27
16 Aug 23BuyUS$4,945John ClimacoIndividual2,750US$1.80

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of CNSP?
Owner TypeNumber of SharesOwnership Percentage
Private Companies10,6420.1%
Institutions249,6162.35%
Hedge Funds676,2036.36%
Individual Insiders1,001,1369.41%
General Public8,697,33581.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 377.7%.


Top Shareholders

Top 25 shareholders own 18.22% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.36%
Armistice Capital LLC
676,203US$147.4k0%no data
5.41%
John Climaco
575,525US$125.5k736%no data
2.37%
Christopher Downs
251,562US$54.8k414%no data
1.09%
Jerzy Gumulka
115,625US$25.2k640%no data
0.85%
Smith Anglin Financial, LLC
90,332US$19.7k80.7%no data
0.55%
The Vanguard Group, Inc.
58,369US$12.7k146%no data
0.31%
Carl Evans
33,458US$7.3k450%no data
0.23%
Geode Capital Management, LLC
24,436US$5.3k0%no data
0.21%
State Street Global Advisors, Inc.
22,556US$4.9k0%no data
0.18%
FSM Wealth Advisors, LLC
19,084US$4.2k0%no data
0.12%
Virtu Financial LLC, Asset Management Arm
13,152US$2.9k0%no data
0.1%
Renaissance Technologies LLC
11,144US$2.4k0%no data
0.094%
XTX Holdings Limited, Asset Management Arm
10,002US$2.2k0%no data
0.08%
Sandra Silberman
8,553US$1.9k16.1%no data
0.063%
Houston Pharmaceuticals, Inc.
6,667US$1.5k0%no data
0.059%
Jeffry Keyes
6,323US$1.4k0%no data
0.056%
Andrzej Andraczke
5,953US$1.3k0%no data
0.037%
Tower Research Capital LLC
3,975US$866.6-16.1%no data
0.02%
Bettina Cockroft
2,086US$454.6201%no data
0.013%
Faith Charles
1,361US$296.816.6%no data
0.0065%
Amy Mahery
690US$150.50%no data
0.002%
Strategic Advisers LLC
212US$46.10%no data
0.0016%
Wells Fargo & Company, Securities and Brokerage Investments
175US$38.3-63.2%no data
0.00063%
Morgan Stanley, Investment Banking and Brokerage Investments
67US$14.60%no data
0.0005%
Global Retirement Partners, LLC
53US$11.60%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.